Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program

CCR2 is the cognate receptor to the chemokine CCL2. CCR2–CCL2 signaling mediates cancer progression and metastasis dissemination. However, the role of CCR2–CCL2 signaling in pathogenesis of B-cell malignancies is not clear. Previously, we showed that CCR2B was upregulated in ex vivo peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozireva, Svetlana, Rudevica, Zhanna, Baryshev, Mikhail, Leonciks, Ainars, Kashuba, Elena, Kholodnyuk, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977232/
https://www.ncbi.nlm.nih.gov/pubmed/29751565
http://dx.doi.org/10.3390/v10050239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977232/
https://www.ncbi.nlm.nih.gov/pubmed/29751565
http://dx.doi.org/10.3390/v10050239

Ejemplares similares